- Home
- Products
Orserdu (Elacestrant)
Orserdu (Elacestrant)
- Medicine Name: Orserdu
- Generic Name: Elacestrant
- Dosage Form & Strength: Tablets – 345 mg and 86 mg
- Manufactured By: Stemline Therapeutics, Inc.
Orserdu (elacestrant) is an estrogen receptor antagonist indicated for postmenopausal women and adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. It is used in patients whose disease has progressed after at least one prior endocrine therapy.
Recommended Dosage:
- 345 mg taken orally once daily with food.
- Continue treatment until disease progression or unacceptable toxicity.
- Swallow tablets whole; do not crush, chew, or split.
If a dose is missed by more than six hours or vomiting occurs, skip the dose and resume the next day at the regular time.
Lipid Abnormalities: Monitor cholesterol and triglyceride levels before starting and periodically during treatment.
Pregnancy Risk: Can cause fetal harm. Use effective contraception during treatment and for 7 days after the last dose.
Breastfeeding: Not recommended during treatment and for 7 days after the final dose due to potential adverse effects in infants.
Hepatic Impairment: Avoid in patients with severe hepatic impairment. Dose adjustments may be required in moderate impairment (Child-Pugh B).
Required Documents for Import:
- Valid prescription from a licensed medical practitioner
- Diagnostic test reports
- Government-issued ID proof of the patient
Order Confirmation:
- Orders are confirmed upon receiving a valid prescription and import permit (if applicable).
Availability in India: Orserdu is accessible in India through Global Rare Meds under the Named Patient Program. We support ethical sourcing from accredited suppliers across the USA, Canada, Europe, and Australia.
Delivery supported across major cities including Mumbai, Chennai, Hyderabad, Delhi, Bangalore, Kolkata, Pune, Ahmedabad, Jaipur, Chandigarh, and others.
To enquire about pricing and process:
- Phone/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
Global Rare Meds ensures secure procurement of Orserdu from certified global suppliers. All prescriptions are verified and dispatched from our fulfillment center in Ambernath, Thane District, ensuring safety and compliance.
We offer reliable logistics for timely delivery across India and select international locations.
What is the Generic Name for Orserdu®?
Elacestrant
Who manufactures Orserdu®?
Stemline Therapeutics, Inc. (a Menarini Group company)
Is Orserdu® FDA approved?
Yes, Orserdu® was approved by the FDA on January 27, 2023.
Where can I get Orserdu® in India?
You can obtain Orserdu through Global Rare Meds with a valid medical prescription.
What form is Orserdu® available in?
Tablets: 345 mg and 86 mg for oral use.
What are the common side effects of Orserdu®? Side effects may include headache, nausea, vomiting, fatigue, hot flushes, decreased appetite, abdominal pain, diarrhea, constipation, and dyspepsia.
How much does Orserdu® cost in India?
Prices vary depending on supply and dosage. For accurate pricing, contact Global Rare Meds at +91-99675 15602 or email info@globalraremeds.com.
Storage Conditions: Store between 20°C to 25°C (68°F to 77°F). Allowable excursions: 15°C to 30°C (59°F to 86°F).
Can I buy Orserdu® online in India safely?
Yes, Global Rare Meds facilitates legal, transparent procurement of Orserdu for eligible patients through named patient import pathways.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
